Status:
ACTIVE_NOT_RECRUITING
A Hybrid Effectiveness Implementation Study of Latino/a Alcohol and Drug Users
Lead Sponsor:
Boston University Charles River Campus
Collaborating Sponsors:
Brown University
National Institutes of Health (NIH)
Conditions:
Alcohol Use Disorder
Drug Use
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Alcohol use is a significant problem among Latinxs and immigration-related stress increases risk for substance use. A theoretically-based cultural adaptation of motivational interviewing (CAMI) that s...
Detailed Description
Alcohol use is a significant problem among Latinxs because of the disproportionate burden of physical harms and negative consequences associated with substance use relative to other racial/ethnic grou...
Eligibility Criteria
Inclusion
- Meets criteria for binge drinking in the past month (\> 4/5 (females/males) drinks/occasion, 1+ days/month)
- Age 18 or older
- Identify as Latinx
- First or second-generation immigrant
Exclusion
- Current psychotic symptoms
- Cognitive impairment
- Currently in psychosocial treatment for alcohol use disorder
- Patients who have been enrolled in the Complex Care Management (CCM) before January 1, 2021.
Key Trial Info
Start Date :
March 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2028
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT04771650
Start Date
March 25 2022
End Date
August 1 2028
Last Update
October 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02215
2
Mercy Medical Center
Springfield, Massachusetts, United States, 01104